bioRxivCancer BiologyPreprint
Granulocyte Derived Resistin Inhibits Monocyte Maturation and Induces Immune Suppression in CMML
Nathan J. HulliD, Rachel CantiD, Laura A Guest, Yu‐Hung WangiD, Kristian GurashiiD, Roberto ParedesiD, Hector Huerga EncaboiD, Chien‐Chin LiniD, Hwei‐Fang TieniD, Robert SellersiD, Sudhakar SahooiD, Dominique A. BonnetiD, Dorothée Selimoglu‐BuetiD, Éric SolaryiD, Daniel H. WisemaniD, Kiran BattaiD
- Citations
- 2
Abstract
Chronic myelomonocytic leukaemia (CMML) is a haematological malignancy characterised by overlapping myeloid dysplasia and proliferation with persisting monocytosis. While monocytes are the cardinal malignant cell type in CMML, as a stem cell neoplasm the disease clone comprises most lineages and differentiation stages, including granulocytes. To investigate the pathogenic contribution of granulocytes in CMML maintenance and progression, we performed phenotypic, transcriptomic and functional characterization of CMML granulocytes. Compared with healthy age-matched controls, CMML granulocytes exhibit defective maturation with reduced granularity and phagocytic capacity. Transcriptome analysis revealed activation of pathways linked to proliferation, Myc activity and inflammation. Notably, RETN, which encodes the inflammatory mediator resistin, was upregulated approximately 100-fold in CMML granulocytes; but not differentially expressed in CMML PBMNCs, sorted monocytes, or stem and progenitor cells compared to their healthy counterparts. Accordingly, resistin protein levels were 10-fold higher in plasma from CMML patients and higher plasma resistin levels correlate with poor overall survival and AML-free survival. Remarkably, exposure of healthy monocytes to exogenous recombinant resistin inhibited monocyte maturation and macrophage differentiation. Transcriptome analysis of resistin treated monocytes revealed that resistin induces gene signatures related to immune suppression and myeloid-derived suppressor cell phenotype. We found SEMA4A to be a downstream target of resistin and overexpressed in CMML monocytes. Consistent with known roles for SEMA4A, CMML patients displayed higher percentage of Tregs and elevated Th2/Th1 ratio compared with healthy controls and percentage of Tregs corresponding with associated resistin levels. Furthermore, we demonstrated that resistin directly skews the Th2/Th1 ratio via binding to monocytes. In conclusion, we showed that immature granulocytes in CMML produce high levels of resistin, which contributes to defective monocyte maturation and immune suppression.
- organism: human
- assay: bulk RNA-seq
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CXCL8 secreted by immature granulocytes inhibits wildtype hematopoiesis in chronic myelomonocytic leukemia
P. Deschamps, M. Wacheux, … D. Selimoglu-Buet·bioRxiv·Mar 8, 2024
- Dysregulated neutrophil extracellular trap formation is a novel driver of clonogenicity and therapeutic vulnerability in CMML
Saveg Yadav, Callie T. Brown, … Ami B. Patel·bioRxiv·Jul 29, 2026
- Dark selection for JAK/STAT-inhibitor resistance in chronic myelomonocytic leukemia
Artem Kaznatcheev, David Robert Grimes, … David Basanta·bioRxiv·Oct 30, 2017
- Indoleamine 2,3-dioxygenase-1 expressing aggregate bone marrow dendritic cell populations are associated with systemic T cell compartment changes in chronic myelomonocytic leukemia
A. Mangaonkar, K. K. Reichard, … M. M. Patnaik·bioRxiv·May 14, 2020
- Heightened NLRP3 inflammasome activation is associated with aging and CMML diseases severity
N. Andina, L. de Meuron, … R. Allam·bioRxiv·Jan 27, 2022
- CCR1 inhibition sensitizes multiple myeloma cells toglucocorticoid therapy
Bert Luyckx, Maaike Van Trimpont, … Karolien De Bosscher·Pharmacological ResearchPeer-reviewed·Mar 23, 2025